Related Experiment Video
Updated: Nov 25, 2025

08:17
Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
Published on: October 30, 2016
21.6K
Prospects for NK Cell Therapy of Sarcoma
Mieszko Lachota1, Marianna Vincenti2, Magdalena Winiarska3
1Department of Clinical Immunology, Doctoral School, Medical University of Warsaw, 02-006 Warsaw, Poland.
Cancers
|December 16, 2020
Summary
Natural killer (NK) cells show promise for treating sarcoma, a type of cancer sensitive to NK cell activity. Understanding how sarcomas evade NK cell attacks is key to developing effective immunotherapies.
Area of Science:
- Immunology
- Oncology
- Cancer Research
Background:
- Natural killer (NK) cells are crucial innate immune cells with significant antitumor capabilities.
- Sarcomas are aggressive cancers highly sensitive to NK cell cytotoxicity, yet advanced stages are often treatment-refractory.
- Current treatments for advanced sarcoma are insufficient, necessitating novel therapeutic approaches.
Purpose of the Study:
- To review the role of NK cells in sarcoma immunosurveillance throughout disease progression.
- To elucidate the mechanisms by which sarcomas suppress NK cell function.
- To identify potential NK cell-based immunotherapies for sarcoma.
Main Methods:
- Literature review of existing studies on NK cells and sarcoma.
- Analysis of NK cell-sarcoma interactions and immune evasion strategies.
- Synthesis of findings to propose therapeutic targets.
Main Results:
- NK cells are involved in immunosurveillance of sarcoma from initiation to metastasis.
- Sarcomas employ diverse mechanisms to evade or suppress NK cell activity.
- Targeting these evasion mechanisms could enhance NK cell-mediated antitumor effects.
Conclusions:
- NK cells represent a promising therapeutic avenue for sarcoma treatment.
- Overcoming sarcoma-induced NK cell suppression is critical for successful immunotherapy.
- Further research into NK-sarcoma crosstalk will guide the development of novel immunotherapies.
Keywords:
Natural Killer (NK) cellsadoptive cell therapycancercell-mediated cytotoxicitychimeric antigen receptor (CAR)immunotherapysarcomasolid tumorstumor microenvironment (TME)More Related Videos
Related Concept Videos
Cytotoxic T Cells-mediated Immune Response
6.1K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.1K
Tumor Immunotherapy
884
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
884

